Pfizer (PFE) news
Recent news
Pfizer - 2026-2027 COVID-19 vaccine formula targets XFG variant per FDA guidance
AInvest Wire · 3d agoPfizer and BioNTech receive U.S. FDA approval for XFG-adapted COVID-19 vaccine
AInvest Wire · 3d ago3SBio H1 revenue RMB 4,526 million
In the first half of 2025, 3SBio Inc. (01530.HK) reported revenue of RMB 4.356 billion , reflecting a significant increase in its financial performance. This figure aligns with the company’s broader strategic focus on innovation and global collaboration, which has driven both revenue and…
AInvest Wire · Aug 20, 2026Sinopharm Group - China National Accord Medicines H1 2026 revenue RMB36.27 billion
Shares of Sinopharm Group Co. Ltd. (1099.HK) have experienced mixed performance in early 2026, with recent quarterly results indicating a decline in profitability amid broader market volatility. On April 27, 2026, the company’s stock touched a 6-month low following the release of its quarterly…
AInvest Wire · Aug 17, 2026Sun Pharma: US appeals court affirmed district court order
A U.S. appeals court has affirmed a district court order in favor of a unit of Sun Pharmaceutical Industries Ltd., dismissing claims that it colluded to delay the generic version of Pfizer Inc.'s cholesterol-lowering drug, Lipitor. The Third Circuit upheld the trial court’s summary judgment, ruling…
AInvest Wire · Aug 17, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.